MicroRNA4500 suppresses tumor progression in nonsmall cell lung cancer by regulating STAT3.
Mol Med Rep
; 20(6): 4973-4983, 2019 Dec.
Article
in En
| MEDLINE
| ID: mdl-31638206
ABSTRACT
Research has revealed that microRNA (miR)4500 is downregulated in nonsmall cell lung cancer (NSCLC), and miR4500 suppresses tumor growth by targeting lin28 homolog B and NRAS protooncogene, GTPase. In the present study, it was reported that signal transducer and activator of transcription 3 (STAT3) may function as a novel target gene for miR4500 in NSCLC. The experiments conducted in the present study confirmed that the miR4500 expression was decreased in NSCLC tissues and cells compared with adjacent normal tissues and a normal lung cell line. miR4500 suppressed the cell proliferation, migration, invasion and promoted apoptosis of the human NSCLC cell lines A549 and H1975. Expression of STAT3 was negatively correlated with miR4500 expression in vivo. A luciferase reporter assay suggested that miR4500 directly targeted the 3' untranslated region of STAT3. The tumor inhibition effect of small interfering RNA STAT3 in A549 and H1975 lines may be partially impaired by a miR4500 inhibitor. The results of the present study suggests that miR4500 may be a tumor suppressor and a potential therapeutic target in NSCLC.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Gene Expression Regulation, Neoplastic
/
Carcinoma, Non-Small-Cell Lung
/
MicroRNAs
/
STAT3 Transcription Factor
/
Lung Neoplasms
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Mol Med Rep
Year:
2019
Document type:
Article